A systematic review analyzing the immunohistochemistry approach to evaluate PD-L1 expression in PCa patients revealed that 29% of acinar tumors, 7% of ductal tumors, and 46% of neuroendocrine carcinomas were positive for PD-L1 expression [100]. Here, CD274 is linked to neuroendocrine carcinoma.